Methyl-MMDA-2

From Wikipedia, the free encyclopedia
Methyl-MMDA-2
Systematic (IUPAC) name
N-methyl-1-(6-methoxy-1,3-benzodioxol-5-yl)propan-2-amine
Clinical data
Legal status Uncontrolled (but may be covered under the Federal Analogue Act in the United States and under similar bills in other countries)
Routes Oral, Insufflated, Rectal
Identifiers
CAS number ?
ATC code None
PubChem CID ?
ChemSpider 23553107
Chemical data
Formula C12H17NO3 
Mol. mass 223.27 g/mol

N-Methyl-2-methoxy-4,5-methylenedioxyamphetamine (Methyl-MMDA-2; 6-Methoxy-MDMA) is a psychedelic drug of the amphetamine class.[1] It is the N-methylated derivative of MMDA-2, and is also an analogue of MDMA and 6-methyl-MDA.[1]

Methyl-MMDA-2 was first synthesized by Alexander Shulgin and was described in his book PiHKAL. He states that it is essentially inactive at a dose of 70 mg, and he did not try any higher;[1] however, Methyl-MMDA-2 is still likely to be active, perhaps in the 125-250 mg range.[citation needed] This reduction in hallucinogenic activity relative to MMDA-2 parallels that of MDA and MDMA, indicating that with phenethylamines, N-methylation substantially reduces 5-HT2A receptor affinity.[1][2]

See also

References

  1. 1.0 1.1 1.2 1.3 Ann Shulgin; Alexander Shulgin (1991). Pihkal: A Chemical Love Story. Transform Press. ISBN 0-9630096-0-5. 
  2. Nichols DE, Oberlender R (1989). "Structure-activity relationships of MDMA-like substances". NIDA Research Monograph 94: 1–29. PMID 2575223. 

External links

This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.